Screener Summaries Updates Institutions Sign In More Updates › Other Events › IDXX Other Events · May 15, 2026
IDEXX Laboratories shareholders approved amendments to declassify the Board of Directors over a three-year period and… IDXX Idexx Laboratories Inc
IDEXX Laboratories shareholders approved amendments to declassify the Board of Directors over a three-year period and granted shareholders with at least 25% ownership the right to call special meetings. A separate shareholder proposal to grant special meeting rights failed, receiving 28,179,566 votes in favor and 40,019,951 against.
More from Idexx Laboratories Inc IDEXX raises 2026 EPS outlook to $14.96-$15.16 and revenue guidance to $4.74B-$4.77B Nov 2, 2026 IDEXX Laboratories reported second quarter 2026 revenue of $1,217 million, a 10% increase as reported and 9% organic… Aug 4, 2026 IDEXX Laboratories, Inc. announced its financial results for the first quarter ended March 31, 2026 May 5, 2026 IDEXX Laboratories announced that Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, will… Mar 26, 2026 IDEXX Laboratories announced its financial results for the fourth quarter and full year ended December 31, 2025 Feb 2, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
